Keywords
MedicineRosuvastatinInternal medicineStatinNational Cholesterol Education ProgramPravastatinMyocardial infarctionC-reactive proteinHyperlipidemiaCholesterolRandomized controlled trialDiseasePhysical therapyCardiologyEndocrinologyDiabetes mellitusMetabolic syndromeInflammationObesity
Affiliated Institutions
Related Publications
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence...
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
Abstract Regional body fat distribution has an important influence on metabolic and cardiovascular risk factors. Increased abdominal (visceral) fat accumulation is a risk factor...
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
Pravastatin did not reduce either all-cause mortality or CHD significantly when compared with usual care in older participants with well-controlled hypertension and moderately e...
Triglycerides and Coronary Heart Disease: Implications of Recent Clinical Trials
This paper reviews the clinical trial data that offer insight into the question of whether, and in what groups of people, triglycerides might be an appropriate therapeutic targe...
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events
Statin therapy may be effective in the primary prevention of coronary events among subjects with relatively low lipid levels but with elevated levels of C-reactive protein.
Publication Info
- Year
- 2003
- Type
- review
- Volume
- 108
- Issue
- 19
- Pages
- 2292-2297
- Citations
- 422
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
422
OpenAlex
Cite This
Paul M. Ridker
(2003).
Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein.
Circulation
, 108
(19)
, 2292-2297.
https://doi.org/10.1161/01.cir.0000100688.17280.e6
Identifiers
- DOI
- 10.1161/01.cir.0000100688.17280.e6